Oct 2026· Translational Oncology· Vol 74· 0 citations· 35 references
Medicine
TL;DR
Findings establish SLCO1B3 as an independent prognostic biomarker and functional driver that sustains stemness and malignant phenotypes in HNSCC, providing a rationale for its therapeutic targeting.
Abstract
Highlights • Elevated SLCO1B3 in HNSCC independently predicts worse survival.• Single-cell profiling links SLCO1B3 to an epithelial subset with enhanced stemness and progenitor traits.• Spatial transcriptomics shows SLCO1B3+ malignant epithelial cells preferentially colocalize with fibroblasts and SMCs.• Functional loss of SLCO1B3 attenuates malignant phenotypes of HNSCC cells.
Intratumoral epithelial heterogeneity contributes to lung adenocarcinoma (LUAD) progression and may limit the interpretability of prognostic models derived from bulk tissue. To characterize this heterogeneity and assess its clinical relevance, four public single-cell RNA-sequencing datasets comprising 193,280 quality-c...
Xiao-Kui Sun, Hang-Bo Shen· Journal of Visualized Experi...· 0 citations
SLC9A3R1 may promote bladder cancer progression through mTOR signaling and represents a potential prognostic biomarker and therapeutic target via differential expression, enrichment, and CIBERSORT analyses.
Yi-Ming Wang, Xiao-Xiang Wu, Chong Shu et al.· Cancer Investigation· 0 citations
INTRODUCTION
SLC7A11 is part of the solute carrier family and encodes the transporter xCT. However, its functional role in renal cell carcinoma (RCC) progression and associated tumor microenvironment (TME) modulation remains poorly characterized and requires further investigation. This study aimed to explore SLC7A11 ex...
Xin-Yang Cheng, Jun Zhang, Ji-Xin Yuan et al.· Current Medicinal Chemistry· 0 citations
PCDHGB4 is a potential biomarker for pan-cancer, especially SCC, and may promote tumor progression through oncogenic signaling and modulation of the tumor immune microenvironment.
Hai-Yue Sun, Xiang Lv, Shao-Lin Liu et al.· Journal of Pharmaceutical In...· 0 citations
Although coiled-coil domain containing 69 (CCDC69) has been implicated in tumor biology, its role in triple-negative breast cancer (TNBC) and immune regulation remains unclear. Bulk transcriptomic data, single-cell RNA sequencing datasets, and spatial transcriptomics were used to investigate the role of CCDC69 in TNBC....
Jin-Jiao Li· Brazilian journal of medical...· 0 citations
Triple-negative breast cancer (TNBC) is characterized by high malignancy, poor prognosis and a lack of specific therapeutic targets. Obesity acts as a major risk factor facilitating TNBC progression, while the molecular features underlying their correlation remain poorly systematically characterized. In this study, w...